↓ Skip to main content

Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits

Overview of attention for article published in Frontiers in Neuroscience, June 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
2 news outlets
twitter
73 X users

Citations

dimensions_citation
187 Dimensions

Readers on

mendeley
306 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits
Published in
Frontiers in Neuroscience, June 2018
DOI 10.3389/fnins.2018.00383
Pubmed ID
Authors

Shreyasi Chatterjee, Amritpal Mudher

Abstract

Alzheimer's disease (AD) and Type 2 Diabetes Mellitus (T2DM) are two of the most prevalent diseases in the elderly population worldwide. A growing body of epidemiological studies suggest that people with T2DM are at a higher risk of developing AD. Likewise, AD brains are less capable of glucose uptake from the surroundings resembling a condition of brain insulin resistance. Pathologically AD is characterized by extracellular plaques of Aβ and intracellular neurofibrillary tangles of hyperphosphorylated tau. T2DM, on the other hand is a metabolic disorder characterized by hyperglycemia and insulin resistance. In this review we have discussed how Insulin resistance in T2DM directly exacerbates Aβ and tau pathologies and elucidated the pathophysiological traits of synaptic dysfunction, inflammation, and autophagic impairments that are common to both diseases and indirectly impact Aβ and tau functions in the neurons. Elucidation of the underlying pathways that connect these two diseases will be immensely valuable for designing novel drug targets for Alzheimer's disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 73 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 306 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 306 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 45 15%
Student > Bachelor 36 12%
Researcher 26 8%
Student > Master 25 8%
Other 11 4%
Other 48 16%
Unknown 115 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 45 15%
Neuroscience 33 11%
Pharmacology, Toxicology and Pharmaceutical Science 26 8%
Medicine and Dentistry 20 7%
Agricultural and Biological Sciences 12 4%
Other 45 15%
Unknown 125 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2022.
All research outputs
#772,578
of 26,399,279 outputs
Outputs from Frontiers in Neuroscience
#325
of 11,853 outputs
Outputs of similar age
#16,254
of 345,299 outputs
Outputs of similar age from Frontiers in Neuroscience
#9
of 227 outputs
Altmetric has tracked 26,399,279 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,853 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,299 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 227 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.